Vaccine developer Johnson & Johnson targeting 100 million doses of a COVID-19 vaccine by March 2021

A representative for Johnson & Johnson told a congressional committee on Tuesday that the company is hopeful a COVID-19 vaccine will be brought to market next year with 100 million doses produced by March.